BDBM436763 2-[6-[5-(Difluoromethyl)-2-thienyl]-3-methyl-2-oxo-imidazo[4,5-b]pyridin-1- yl]-N,N-dimethyl-acetamide::US10617676, Example 94::US11207298, Example 94

SMILES CN(C)C(=O)Cn1c2cc(cnc2n(C)c1=O)-c1ccc(s1)C(F)F

InChI Key InChIKey=VMNLQDPQMDGDRZ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 436763   

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM436763(US10617676, Example 94 | 2-[6-[5-(Difluoromethyl)-...)
Affinity DataIC50: 17nMAssay Description:NMDA receptors are ion channels that are highly permeable to Ca2+ ions, rendering it possible to monitor NMDA receptor function using cell-based calc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2020
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1/2B(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM436763(US10617676, Example 94 | 2-[6-[5-(Difluoromethyl)-...)
Affinity DataIC50: 17nMAssay Description:NMDA receptors are ion channels that are highly permeable to Ca2+ ions, rendering it possible to monitor NMDA receptor function using cell-based calc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
Go to US Patent